Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neuroendocrine Neoplasm”

1,302 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,302 results

Testing effectiveness (Phase 2)Study completedNCT00089219
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Virginia 39
Testing effectiveness (Phase 2)Ended earlyNCT05949632
What this trial is testing

INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Incyte Corporation 5
Early research (Phase 1)Ended earlyNCT06270082
What this trial is testing

Study of IK-595 in RAS- or RAF-altered Advanced Tumors

Who this might be right for
Solid Tumor, AdultColorectal CancerPancreatic Cancer+7 more
Ikena Oncology 75
Early research (Phase 1)Study completedNCT03881488
What this trial is testing

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

Who this might be right for
Locally Advanced Solid TumorMetastatic CancerNon-small Cell Lung Cancer+4 more
Compass Therapeutics 100
Early research (Phase 1)Study completedNCT01738139
What this trial is testing

Ipilimumab and Imatinib Mesylate in Advanced Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmC-KIT Tyrosine Kinase Protein OverexpressionClinical Stage IV Cutaneous Melanoma AJCC v8+6 more
M.D. Anderson Cancer Center 68
Testing effectiveness (Phase 2)Looking for participantsNCT06683846
What this trial is testing

Ivonescimab in the Treatment of Multiple Advanced Tumors

Who this might be right for
Pheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more
Fudan University 400
Not applicableStudy completedNCT04229277
What this trial is testing

Fast Track Diagnosis of Skin Cancer by Advanced Imaging

Who this might be right for
Malignant MelanomaNevus, PigmentedBasal Cell Carcinoma+1 more
University Hospital Bispebjerg and Frederiksberg 41
Testing effectiveness (Phase 2)Looking for participantsNCT07070518
What this trial is testing

Study of GV20-0251 in Participants With Solid Tumor Malignancies

Who this might be right for
Solid Tumor CancerAdult Refractory CancerEndometrial Carcinoma (EC)+6 more
GV20 Therapeutics 350
Not applicableNo Longer AvailableNCT04289155
What this trial is testing

Individual Patient Compassionate Use of GX-I7

Who this might be right for
GlioblastomaHigh Grade GliomaRecurrent Glioblastoma+2 more
Genexine, Inc.
Not applicableStudy completedNCT02372708
What this trial is testing

Clinical Research on the Treatments on Advanced Malignant Melanoma by Combining in Situ Immunotherapy and Laser Therapy

Who this might be right for
Melanoma
Chinese PLA General Hospital 72
Testing effectiveness (Phase 2)Study completedNCT02645149
What this trial is testing

Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 216
Testing effectiveness (Phase 2)Study completedNCT04208958
What this trial is testing

Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer

Who this might be right for
Metastatic CancerMelanomaGastric Cancer+2 more
Vedanta Biosciences, Inc. 56
Testing effectiveness (Phase 2)Ended earlyNCT01820364
What this trial is testing

LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma

Who this might be right for
Melanoma
Array BioPharma 15
Testing effectiveness (Phase 2)Study completedNCT02403778
What this trial is testing

Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma

Who this might be right for
Melanoma
University of Colorado, Denver 10
Not applicableUnknownNCT03210935
What this trial is testing

French National Database of Rare Dermatological Cancers

Who this might be right for
Adnexal Tumor of SkinMerkel Cell CarcinomaAdvanced Basal Cell Carcinoma Requiring Systemic Treatment
University Hospital, Lille 9,000
Testing effectiveness (Phase 2)WithdrawnNCT01736878
What this trial is testing

Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma

Who this might be right for
Medullary Thyroid Carcinoma
Eanm Research Ltd
Not applicableUnknownNCT00264056
What this trial is testing

Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases

Who this might be right for
Advanced Metastastic Malignant MelanomaRefractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases
Fachklinik Hornheide an der Universität Münster 26
Early research (Phase 1)Looking for participantsNCT05266612
What this trial is testing

Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumor
Virogin Biotech Canada Ltd 12
Testing effectiveness (Phase 2)UnknownNCT05675605
What this trial is testing

TY-1091 in Patients With Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+1 more
TYK Medicines, Inc 248
Testing effectiveness (Phase 2)Looking for participantsNCT06283719
What this trial is testing

Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerNeuroendocrine Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 265
Load More Results